These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 36983883)

  • 1. The Eye as a Diagnostic Tool for Alzheimer's Disease.
    Hussain A; Sheikh Z; Subramanian M
    Life (Basel); 2023 Mar; 13(3):. PubMed ID: 36983883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond Vision: A View from Eye to Alzheimer's Disease and Dementia.
    Zheng C; Zeng R; Wu G; Hu Y; Yu H
    J Prev Alzheimers Dis; 2024; 11(2):469-483. PubMed ID: 38374754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular Manifestations of Alzheimer's and Other Neurodegenerative Diseases: The Prospect of the Eye as a Tool for the Early Diagnosis of Alzheimer's Disease.
    Colligris P; Perez de Lara MJ; Colligris B; Pintor J
    J Ophthalmol; 2018; 2018():8538573. PubMed ID: 30151279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Ocular Biomarkers for Early Detection of Alzheimer's Disease and Their Roles in Artificial Intelligence Studies.
    Chaitanuwong P; Singhanetr P; Chainakul M; Arjkongharn N; Ruamviboonsuk P; Grzybowski A
    Neurol Ther; 2023 Oct; 12(5):1517-1532. PubMed ID: 37468682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers and Tools for Predicting Alzheimer's Disease in the Preclinical Stage.
    Li TR; Yang Q; Hu X; Han Y
    Curr Neuropharmacol; 2022; 20(4):713-737. PubMed ID: 34030620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease.
    Shah TM; Gupta SM; Chatterjee P; Campbell M; Martins RN
    Mol Psychiatry; 2017 Mar; 22(3):353-363. PubMed ID: 28093567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of Alzheimer's disease utilizing amyloid and tau as fluid biomarkers.
    Lee JC; Kim SJ; Hong S; Kim Y
    Exp Mol Med; 2019 May; 51(5):1-10. PubMed ID: 31073121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Eye As a Biomarker for Alzheimer's Disease.
    Lim JK; Li QX; He Z; Vingrys AJ; Wong VH; Currier N; Mullen J; Bui BV; Nguyen CT
    Front Neurosci; 2016; 10():536. PubMed ID: 27909396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease and blood-based biomarkers - potential contexts of use.
    Zvěřová M
    Neuropsychiatr Dis Treat; 2018; 14():1877-1882. PubMed ID: 30050302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021.
    Porsteinsson AP; Isaacson RS; Knox S; Sabbagh MN; Rubino I
    J Prev Alzheimers Dis; 2021; 8(3):371-386. PubMed ID: 34101796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Algorithm for Preclinical Diagnosis of Alzheimer's Disease.
    Khan TK
    Front Neurosci; 2018; 12():275. PubMed ID: 29760644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current opinion neurology: visual pathway biomarkers in Alzheimer's disease.
    Van Stavern GP
    Curr Opin Neurol; 2020 Feb; 33(1):79-86. PubMed ID: 31809334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin.
    Carro E; Bartolomé F; Bermejo-Pareja F; Villarejo-Galende A; Molina JA; Ortiz P; Calero M; Rabano A; Cantero JL; Orive G
    Alzheimers Dement (Amst); 2017; 8():131-138. PubMed ID: 28649597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relative contributions of biomarkers, disease modifying treatment, and dementia severity to Alzheimer's stigma: A vignette-based experiment.
    Stites SD; Gill J; Largent EA; Harkins K; Sankar P; Krieger A; Karlawish J
    Soc Sci Med; 2022 Jan; 292():114620. PubMed ID: 34883313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Body-Fluid Biomarkers in Alzheimer's Disease Diagnosis.
    Nguyen TT; Ta QTH; Nguyen TKO; Nguyen TTD; Vo VG
    Diagnostics (Basel); 2020 May; 10(5):. PubMed ID: 32443860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Diagnosis of Alzheimer's Disease with Blood Test; Tempting but Challenging.
    Farvadi F; Hashemi F; Amini A; Alsadat Vakilinezhad M; Raee MJ
    Int J Mol Cell Med; 2023; 12(2):172-210. PubMed ID: 38313372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.
    Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z
    BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.